← Browse by Condition
Medical Condition

otcd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06488313 Phase 2
Recruiting

A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

Enrollment
9 pts
Location
United States
Sponsor
Arcturus Therapeutics, Inc.
View Trial →